| 发明名称 |
CDC7 inhibitors |
| 摘要 |
The present invention provides isoindolinone compounds, or a pharmaceutically acceptable salt thereof, that inhibit CDC7 and, therefore may be useful in treating cancer. |
| 申请公布号 |
US9156824(B2) |
申请公布日期 |
2015.10.13 |
| 申请号 |
US201414200141 |
申请日期 |
2014.03.07 |
| 申请人 |
Eli Lilly and Company |
发明人 |
Dally Robert Dean;Woods Timothy Andrew |
| 分类号 |
C07D401/12;C07D239/42;C07D403/14 |
主分类号 |
C07D401/12 |
| 代理机构 |
|
代理人 |
Hostettler Danica |
| 主权项 |
1. A compound which is 3-(5-fluoropyrimidin-4-yl)-3-methyl-6-(1H-pyrazol-4-yl)isoindolin-1-one, or a pharmaceutically acceptable salt or hydrate thereof. |
| 地址 |
Indianapolis IN |
